%0 Journal Article
%T Indoleamine 2,3-dioxygenase expression in patients with allergic rhinitis: a case-control study
%A Annika Luukkainen
%A Jussi Karjalainen
%A Teemu Honkanen
%A Mikko Lehtonen
%A Timo Paavonen
%A Sanna Toppila-Salmi
%J Clinical and Translational Allergy
%D 2011
%I BioMed Central
%R 10.1186/2045-7022-1-17
%X Our aim was to evaluate the expression of IDO in the nasal mucosa of allergic rhinitis patients allergic to birch pollen during peak exposure to birch pollen allergen and compare it to non-atopic patients.IDO expression was immunohistochemically evaluated from nasal specimens obtained in- and off-season from otherwise healthy non-smoking volunteers both allergic to birch pollen (having mild or moderate allergic rhinoconjunctivitis) and non-allergic controls. Results: The IDO expression levels were low in healthy controls and remained low also in patients allergic to birch pollen. There were no differences in the expression of IDO in- and off-season in either healthy or allergic subjects.There is a controversy in the role of IDO in upper and lower airways during allergic airway disease. It seems that IDO is associated to allergic inflammations of the lower airways, but does not have a local role in the nasal cavity at least in mild or moderate forms of allergic rhinitis.Indoleamine 2,3 dioxygenase (IDO) is an intracellular enzyme that initiates the first and rate-limiting step of tryptophan breakdown along the kynurenine pathway [1]. IDO is widely expressed in a variety of cell types including leukocytes and tumour cells [2]. Initially the role of IDO was thought to be mainly antimicrobial by reducing the availability of the essential amino acid tryptophan in the inflammatory environment [3]. In the past years, IDO has emerged as an important regulator of the immune system; however, it is not known whether local IDO activity is beneficial or detrimental to inflamed tissues. IDO is induced by interferon ¦Ã (IFN-¦Ã) and other inflammatory cytokines during inflammation or as a consequence of normal tissue function [4]. IDO suppresses T cell activity and promotes T cell tolerance to further antigenic challenges, by promoting the differentiation of na£¿ve CD4 T cells into regulatory T cells, putatively by regulation by dendritic cells [5-10]. IDO seems to serve as a negative
%K Indoleamine 2
%K 3-dioxygenase
%K allergic rhinitis
%K birch pollen
%K dendritic cell
%K tryptophan
%K kynurenine
%K interferon gamma
%K leukocyte
%K eosinophil
%U http://www.ctajournal.com/content/1/1/17